EW FY 2018 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$49B

FY 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3.7B+8.4% YoY

Gross Profit

$2.8B75.2% margin

Operating Income

$1.1B29.3% margin

Net Income

$722M19.4% margin

EPS (Diluted)

$1.13

Cash Flow

Operating Cash Flow

$927M

Free Cash Flow

$685M

Stock-Based Comp.

$71M

Balance Sheet

Total Assets

$5.3B

Total Liabilities

$2.2B

Stockholders' Equity

$3.1B

Cash & Equivalents

$714M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.7B	$3.4B	+8.4%
Gross Profit	$2.8B	$2.6B	+9.7%
Operating Income	$1.1B	$1.0B	+8.1%
Net Income	$722M	$622M	+16.1%